Lobe Sciences Ltd. C.LOBE

Alternate Symbol(s): LOBEF

Healthcare Drug Manufacturers - Major

Lobe Sciences is a leading “BioPsychedelic” company entering clinical stage development focused on transforming psychedelic medicine to benefit patients of all ages. We are engaged in research and development using psychedelic and non-psychedelic compounds targeting the 5HT2 receptor family. Our team is made up of biotech executives who collectively have managed the development and regulatory approval of revolutionary drugs around the globe.

CSE:LOBE - Post by User

Lobe Sciences Ltd. > NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

<< Previous

Bullboard Posts

Next >>

Comment by Marcinon Jun 16, 2022 12:45pm

113 Views

Post# 34761738

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

initforthemush wrote: Newsfile Corp. - June 14, 2022) - Lobe Sciences Ltd. (CSE: LOBE) Lobe is preparing a pre-IND meeting request with the US Food and Drug Administration (FDA) to confirm its regulatory strategy and Phase I clinical protocols. We expect to have this meeting in the 3rd quarter of 2022.

" I look forward to keeping our shareholders informed as the year unfolds "
--- Philip J Young, CEO

Looks like it's going to run soon

<< Previous

Bullboard Posts

Next >>

This company starts production at what could be Canada’s next great gold mine